Skip to content

Richard H. Rech

13 papers in the library · 54 citations · publishing 1980-1987

Papers

Sort Most recent Most cited

The effects of intracranial administration of hallucinogens on operant behavior in the rat. II. 2,5-Dimethoxy-4-methylamphetamine (DOM).

Pharmacology, Biochemistry, and Behavior November 1987 David J. Mokler, K W Stoudt, L C Sherman et al.

2,5-Dimethoxy-4-methylamphetamine (DOM) was infused into discrete brain regions of rats trained to press a bar for food reinforcement on a fixed ratio-40 (FR-40). Sites were chosen as major areas of the brain 5-hydroxytryptamine (5-HT) system: the dorsal and median raphe nuclei, dorsal hippocampus, lateral habenular nuclei and the prefrontal cortex. Following training in a fixed ratio-40...

The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs.

Pharmacology, Biochemistry, and Behavior May 1985 David J. Mokler, K W Stoudt, Richard H. Rech

Indolealkylamine and phenethylamine hallucinogens disrupted responding maintained under a fixed-ratio 40 (FR-40) schedule of reinforcement. LSD, DMT, mescaline and DOM produced dose-dependent decreases in number of reinforcers and increases in 10-sec periods of non-responding (pause-intervals). The 5HT agonist quipazine, as well as the LSD congener lisuride, altered response patterns in a...

Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.

Pharmacology, Biochemistry, and Behavior September 1984 David J. Mokler, Randall L. Commissaris, J W Henck et al.

Administration of the indolealkylamine hallucinogen d-lysergic acid diethylamide (LSD), the phenethylamine hallucinogen 2,5-dimethoxy-4-methylamphetamine (DOM) and the putative 5-hydroxytryptamine (5-HT) agonist quipazine all produced a dose-dependent decrease in fixed ratio (FR-40) response rates and a concomitant increase in the number of 10-second pause intervals. Although naloxone (4.0...

Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride

Pharmacology, Biochemistry, and Behavior August 1, 1984 David J. Mokler, Richard H. Rech 17 citations

The effects on a fixed ratio-40 (FR-40) operant behavior of intracerebroventricular (ICV) administration of the hallucinogens lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM), mescaline or the non-hallucinogenic LSD-analogue lisuride were compared with intraperitoneal (IP) administration. Infusion of LSD (8.5 to 34 micrograms) into the left lateral ventricle produced a...

Interactions of metergoline with diazepam, quipazine, and hallucinogenic drugs on a conflict behavior in the rat

Psychopharmacology March 1, 1982 Randall L. Commissaris, Richard H. Rech

The effects of diazepam quipazine, lysergic acid diethylamide (LSD), and 2,5-dimethoxy-4-methylamphetamine (DOM) were examined on a conditioned suppression paradigm. Food-deprived rats were trained to drink a liquid diet from a tube. Subsequently, intermittent 7-s tones were presented during the daily 10-min sessions, the tube being electrified during the last 5 s of each tone. The subject...

Neurotransmitter basis of the behavioral effects of hallucinogens.

Neuroscience & Biobehavioral Reviews 1982 Richard H. Rech, Randall L. Commissaris

Indole and phenethylamine-type hallucinogenic drugs were studied in an FR-40 operant behavioral procedure programmed to quantify "pausing,"-a behavioral disruption somewhat specific to hallucinatory drug effects. LSD, DOM, DMT and mescaline showed a potency ratio to produce pausing that is well correlated with the hallucinatory potencies of these agents in man. Furthermore, combinations of the...

Antagonism of the behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and quipazine by metergoline.

Pharmacology, Biochemistry, and Behavior October 1981 Randall L. Commissaris, Richard H. Rech

The present study examined the disruptive effects of the phenethylamine hallucinogen 2,5-dimethoxy-4-methylamphetamine (DOM) and the putative 5-hydroxytryptamine (5-HT) agonist quipazine on fixed ratio-40 (FR-40) operant responding alone or after pretreatment with putative 5-HT antagonist metergoline. Food-deprived male rats were trained to bar press on a FR-40 schedule for food reinforcements;...

The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle.

Pharmacology, Biochemistry, and Behavior June 1981 Randall L. Commissaris, David J. Mokler, William H. Lyness et al.

The hypothesis that 5-hydroxytryptamine (5-HT) neurons and/or receptors are involved in the mechanism of action of hallucinogens is supported by the fact that intraventricular administration of the neurotoxin 5,7-dihydroxytryptamine (5,7-DHT) selectively destroys central 5-HT neurons in the brain and potentiates the behavioral effects of lysergic acid diethylamide (LSD),...

The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM), pentobarbital and methaqualone on punished responding in control and 5,7-dihydroxytryptamine-treated rats

Pharmacology, Biochemistry, and Behavior May 1, 1981 Randall L. Commissaris, William H. Lyness, Richard H. Rech 29 citations

The purpose of the present study was to determine the role of central 5-hydroxytryptamine (5-HT) neuronal systems in the effects of d-lysergic acid diethylamide (LSD), 2,5-methoxy-4-methylamphetamine (DOM), pentobarbital (PB) and methaqualone (MQ) on punished responding in rats. Water-deprived rats were trained to drink from a tube that was electrified at intervals (variable interval 21 sec;...

Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats.

Pharmacology, Biochemistry, and Behavior May 1981 Randall L. Commissaris, William H. Lyness, K E Moore et al.

The present study was designed to examine the role of 5-hydroxytryptamine (5-HT) neurons in the behavioral effects of d-lysergic acid diethylamide (LSD), an indolealkylamine hallucinogen, 2.5-dimethoxy-4-methylamphetamine (DOM) and mescaline, phenethylamine hallucinogens, and phenobarbital, a non-hallucinogen. Male rats, maintained at 70-80% of their free-feeding weights, were trained to press...

The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.

Pharmacology, Biochemistry, and Behavior November 1980 Randall L. Commissaris, William H. Lyness, J J Cordon et al.

The purpose of the present study was to determine the role of central catecholaminergic neuronal systems in the effects of LSD, DOM and d-amphetamine on fixed ratio (FR) operant responding in rats. Food-deprived male rats were trained to press a bar for food reinforcement on a FR-40 schedule. Control responding on this schedule is characterized by a rapid, constant rate of responding...

Naloxone potentiates the disruptive effects of mescaline on operant responding in the rat

Pharmacology, Biochemistry, and Behavior October 1, 1980 Randall L. Commissaris, K.E. Moore, Richard H. Rech 8 citations

Food-deprived male rats were trained to press a lever on a fixed ratio-40 (FR-40) operant schedule for food reinforcement. Administration of mescaline (4.0--10.0 mg/kg) immediately before the start of the operant session resulted in a cessation of responding for some portion of the 40-min period ("hallucinatory pause"). The duration of this pause was found to be dose-dependent. Although...

DOI: 10.1016/0091-3057(80)90289-0 (opens in new tab) Mescaline +-naloxone Pharmacology Antagonist +5

Enhancement of the behavioral effects of 2,5-dimethoxy-4-methyl-amphetamine (DOM) by pretreatment with p-chlorophenylalanine.

Pharmacology, Biochemistry, and Behavior October 1980 Randall L. Commissaris, William H. Lyness, K E Moore et al.

Seven food deprived male rats were trained to press a bar on a fixed ratio-40 (FR-40) schedule of food reinforcement. Administration of 0.5 mg/kg 2,5-dimethoxy-4-methyl amphetamine (DOM) immediately before the start of the session resulted in cessation of responding for some portion of the 40-min test session. Three successive days of p-chlorophenylalanine (PCPA) administration (100 mg/kg) 30...